Cédric Rébé

9.7k total citations · 2 hit papers
70 papers, 6.7k citations indexed

About

Cédric Rébé is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Cédric Rébé has authored 70 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 29 papers in Immunology and 27 papers in Oncology. Recurrent topics in Cédric Rébé's work include Immune Cell Function and Interaction (14 papers), Cell death mechanisms and regulation (13 papers) and Inflammasome and immune disorders (13 papers). Cédric Rébé is often cited by papers focused on Immune Cell Function and Interaction (14 papers), Cell death mechanisms and regulation (13 papers) and Inflammasome and immune disorders (13 papers). Cédric Rébé collaborates with scholars based in France, United States and Canada. Cédric Rébé's co-authors include François Ghiringhelli, Lionel Apétoh, Fanny Chalmin, Mélanie Bruchard, Angélique Chevriaux, Grégoire Mignot, Sylvain Ladoire, Valentin Dérangère, Frédérique Végran and Éric Solary and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Cédric Rébé

69 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity

2010 969 citations Julie Vincent, Grégoire Mignot et al. Cancer Research profile →
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

2012 615 citations Mélanie Bruchard, Grégoire Mignot et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cédric Rébé France	42	3.3k	2.8k	2.5k	734	515	70	6.7k
Andreas Weigert Germany	46	3.3k 1.0×	3.5k 1.2×	1.3k 0.5×	1.1k 1.5×	379 0.7×	203	7.2k
Probir Chakravarty United Kingdom	45	3.9k 1.2×	3.4k 1.2×	3.0k 1.2×	1.2k 1.6×	438 0.9×	112	8.8k
Shabnam Shalapour United States	26	2.0k 0.6×	2.8k 1.0×	1.7k 0.7×	975 1.3×	577 1.1×	40	6.0k
Marco J. Herold Australia	43	2.9k 0.9×	4.6k 1.6×	1.8k 0.7×	825 1.1×	421 0.8×	136	7.9k
Agostino Tafuri Italy	36	2.3k 0.7×	4.3k 1.5×	1.7k 0.7×	787 1.1×	304 0.6×	160	8.3k
Julianna Blagih Canada	23	3.2k 1.0×	3.2k 1.1×	1.4k 0.5×	2.0k 2.7×	380 0.7×	29	6.8k
Bo Hu China	38	1.5k 0.5×	2.9k 1.0×	2.5k 1.0×	1.7k 2.3×	836 1.6×	118	6.7k
Stefan Krautwald Germany	37	2.3k 0.7×	3.3k 1.2×	753 0.3×	683 0.9×	394 0.8×	59	5.9k
Patricia Loughran United States	41	2.9k 0.9×	2.8k 1.0×	729 0.3×	613 0.8×	699 1.4×	109	7.0k
Ryan D. Michalek United States	23	3.0k 0.9×	2.1k 0.8×	882 0.4×	1.1k 1.5×	369 0.7×	35	5.7k

Countries citing papers authored by Cédric Rébé

Since Specialization

Citations

This map shows the geographic impact of Cédric Rébé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cédric Rébé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cédric Rébé more than expected).

Fields of papers citing papers by Cédric Rébé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cédric Rébé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cédric Rébé. The network helps show where Cédric Rébé may publish in the future.

Co-authorship network of co-authors of Cédric Rébé

This figure shows the co-authorship network connecting the top 25 collaborators of Cédric Rébé. A scholar is included among the top collaborators of Cédric Rébé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cédric Rébé. Cédric Rébé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rébé, Cédric & François Ghiringhelli. (2025). Interleukin-1β and cancer immune response. Seminars in Immunology. 80. 102002–102002.

Ghiringhelli, François & Cédric Rébé. (2023). Using immunogenic cell death to improve anticancer efficacy of immune checkpoint inhibitors: From basic science to clinical application. Immunological Reviews. 321(1). 335–349. 16 indexed citations

Ladoire, Sylvain, Cédric Rébé, & François Ghiringhelli. (2022). Associating Immunotherapy and Targeted Therapies: Facts and Hopes. Clinical Cancer Research. 29(7). 1183–1193. 6 indexed citations

Bruchard, Mélanie, Caroline Truntzer, Elise Ballot, et al.. (2022). Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses. Nature Immunology. 23(2). 262–274. 62 indexed citations

Ghiringhelli, François, et al.. (2022). Tumor Immunogenic Cell Death as a Mediator of Intratumor CD8 T-Cell Recruitment. Cells. 11(22). 3672–3672. 35 indexed citations

Berger, Hélène, Cédric Rébé, Elise Ballot, et al.. (2021). Follicular helper-T cells restore CD8⁺-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy. Journal for ImmunoTherapy of Cancer. 9(6). e002157–e002157. 79 indexed citations

Ghiringhelli, François, et al.. (2020). Understanding Inflammasomes and PD-1/PD-L1 Crosstalk to Improve Cancer Treatment Efficiency. Cancers. 12(12). 3550–3550. 17 indexed citations

Rébé, Cédric, François Ghiringhelli, & Carmen Garrido. (2020). Can the hyperthermia‐mediated heat shock factor/heat shock protein 70 pathway dampen the cytokine storm during SARS‐CoV‐2 infection?. British Journal of Pharmacology. 179(21). 4910–4916. 7 indexed citations

Pilot, Thomas, Emeric Limagne, Valentin Dérangère, et al.. (2020). Heat shock and HSP70 regulate 5-FU-mediated caspase-1 activation in myeloid-derived suppressor cells and tumor growth in mice. Journal for ImmunoTherapy of Cancer. 8(1). e000478–e000478. 16 indexed citations

10.

Rébé, Cédric & François Ghiringhelli. (2020). Interleukin-1β and Cancer. Cancers. 12(7). 1791–1791. 217 indexed citations

11.

Chevriaux, Angélique, Valentin Dérangère, Lionel Apétoh, et al.. (2019). HSP70 is a negative regulator of NLRP3 inflammasome activation. Cell Death and Disease. 10(4). 256–256. 89 indexed citations

12.

Rébé, Cédric, et al.. (2019). Heat Shock Proteins and Inflammasomes. International Journal of Molecular Sciences. 20(18). 4508–4508. 47 indexed citations

13.

Dérangère, Valentin, Thomas Pilot, Angélique Chevriaux, et al.. (2019). Hypotonic stress enhances colon cancer cell death induced by platinum derivatives and immunologically improves antitumor efficacy of intraperitoneal chemotherapy. International Journal of Cancer. 145(11). 3101–3111. 3 indexed citations

14.

Rébé, Cédric, et al.. (2019). Platinum Derivatives Effects on Anticancer Immune Response. Biomolecules. 10(1). 13–13. 55 indexed citations

15.

Rébé, Cédric & François Ghiringhelli. (2019). STAT3, a Master Regulator of Anti-Tumor Immune Response. Cancers. 11(9). 1280–1280. 99 indexed citations

16.

Limagne, Emeric, Romain Euvrard, Marion Thibaudin, et al.. (2016). Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen. Cancer Research. 76(18). 5241–5252. 213 indexed citations

17.

Bruchard, Mélanie, Cédric Rébé, Valentin Dérangère, et al.. (2015). The receptor NLRP3 is a transcriptional regulator of TH2 differentiation. Nature Immunology. 16(8). 859–870. 299 indexed citations

18.

Berger, Hélène, Frédérique Végran, Federica Gilardi, et al.. (2013). SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer Growth. Cancer Research. 73(12). 3578–3590. 47 indexed citations

19.

Vincent, Julie, Grégoire Mignot, Fanny Chalmin, et al.. (2010). 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity. Cancer Research. 70(8). 3052–3061. 969 indexed citations breakdown →

20.

Cathelin, Séverine, Cédric Rébé, Frédèrique Verdier, et al.. (2006). Identification of Proteins Cleaved Downstream of Caspase Activation in Monocytes Undergoing Macrophage Differentiation. Journal of Biological Chemistry. 281(26). 17779–17788. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact